日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Denileukin Diftitox-Cxdl(一种纯度更高的 Denileukin Diftitox 制剂)在复发或难治性皮肤 T 细胞淋巴瘤患者中的疗效和安全性

Foss, Francine M; Kim, Youn H; Prince, H Miles; Akilov, Oleg E; Querfeld, Christiane; Seminario-Vidal, Lucia; Fisher, David C; Kuzel, Timothy M; Yannakou, Costas K; Geskin, Larisa J; Feldman, Tatyana; Sokol, Lubomir; Allen, Pamela Blair; Dang, Nam Hoang; Cabanillas, Fernando; Wong, Henry K; Ooi, Chean Eng; Xing, Dongyuan; Sauter, Nicholas; Singh, Preeti; Czuczman, Myron; Duvic, Madeleine

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE(2)-receptor E-type 4 (EP4), in patients with advanced cancers

首次人体 I 期研究,评估免疫调节剂 E7046(一种 PGE(2) 受体 E 型 4 (EP4) 拮抗剂)在晚期癌症患者中的疗效

Hong, David S; Parikh, Aparna; Shapiro, Geoffrey I; Varga, Andrea; Naing, Aung; Meric-Bernstam, Funda; Ataman, Özlem; Reyderman, Larisa; Binder, Terri A; Ren, Min; Liu, Mingjie; Dayal, Satish; Siu, Amy Y; Sachdev, Pallavi; Xu, Lucy; Bhagawati-Prasad, Vijay; Tchakov, Ilian; Ooi, Chean Eng; Bao, Xingfeng; Marabelle, Aurelien